These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 28900867)

  • 1. Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.
    Stylianou E
    Mol Diagn Ther; 2018 Feb; 22(1):11-23. PubMed ID: 28900867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.
    Titz B; Gadaleta RM; Lo Sasso G; Elamin A; Ekroos K; Ivanov NV; Peitsch MC; Hoeng J
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating omics: the future of IBD?
    Fiocchi C
    Dig Dis; 2014; 32 Suppl 1():96-102. PubMed ID: 25531360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Bowel Disease Meets Systems Biology: A Multi-Omics Challenge and Frontier.
    Palmieri O; Mazza T; Castellana S; Panza A; Latiano T; Corritore G; Andriulli A; Latiano A
    OMICS; 2016 Dec; 20(12):692-698. PubMed ID: 27930092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems biology in inflammatory bowel diseases: ready for prime time.
    Polytarchou C; Koukos G; Iliopoulos D
    Curr Opin Gastroenterol; 2014 Jul; 30(4):339-46. PubMed ID: 24837229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiopathogenesis of inflammatory bowel disease: today and tomorrow.
    de Souza HSP
    Curr Opin Gastroenterol; 2017 Jul; 33(4):222-229. PubMed ID: 28402995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IBD and the gut microbiota--from bench to personalized medicine.
    Bellaguarda E; Chang EB
    Curr Gastroenterol Rep; 2015 Apr; 17(4):15. PubMed ID: 25762474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics analysis of inflammatory bowel disease.
    Huang H; Vangay P; McKinlay CE; Knights D
    Immunol Lett; 2014 Dec; 162(2 Pt A):62-8. PubMed ID: 25131220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-environment interactions in inflammatory bowel disease pathogenesis.
    Wang MH; Achkar JP
    Curr Opin Gastroenterol; 2015 Jul; 31(4):277-82. PubMed ID: 26039718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine.
    Kumar M; Garand M; Al Khodor S
    J Transl Med; 2019 Dec; 17(1):419. PubMed ID: 31836022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics and metabolomics in inflammatory bowel disease.
    Yau Y; Leong RW; Zeng M; Wasinger VC
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1076-86. PubMed ID: 23489082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Yamamoto-Furusho JK; Fonseca-Camarillo G
    Inflamm Bowel Dis; 2015 Nov; 21(11):2683-95. PubMed ID: 26244649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism.
    Moco S; Candela M; Chuang E; Draper C; Cominetti O; Montoliu I; Barron D; Kussmann M; Brigidi P; Gionchetti P; Martin FP
    Inflamm Bowel Dis; 2014 Nov; 20(11):2104-14. PubMed ID: 25029616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Omics Analysis of Gut Microbiota in Inflammatory Bowel Diseases: What Benefits for Diagnostic, Prognostic and Therapeutic Tools?
    Lacroix V; Cassard A; Mas E; Barreau F
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic background of inflammatory bowel disease: from correlation to causality.
    Uniken Venema WT; Voskuil MD; Dijkstra G; Weersma RK; Festen EA
    J Pathol; 2017 Jan; 241(2):146-158. PubMed ID: 27785786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating multiple 'omics' analysis for microbial biology: application and methodologies.
    Zhang W; Li F; Nie L
    Microbiology (Reading); 2010 Feb; 156(Pt 2):287-301. PubMed ID: 19910409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy.
    de Souza HSP; Fiocchi C; Iliopoulos D
    Nat Rev Gastroenterol Hepatol; 2017 Dec; 14(12):739-749. PubMed ID: 28831186
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.